Valuation and Earnings This table compares Merck KGaA and Virpax Pharmaceuticals”s gross revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Merck KGaA $22.72 billion 0.90 $3.06 billion $6.81 23.14 Virpax Pharmaceuticals N/A N/A -$15.19 million ($123.25) 0.00 Merck KGaA has higher revenue and earnings than […]

Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) and Merck KGaA (OTCMKTS:MKKGY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations. Analyst Recommendations This is a summary of current […]